Search

everythinglearnresearchcommunity

for

Search:↓

A topical BRAF inhibitor, vemurafenib, can speed up wound healing and promote hair growth, especially in diabetic patients.

Stopping mitochondrial respiration can prevent brain cancer spread in skin cancer patients, and plant compound β-sitosterol could help achieve this.

Dermatologists are crucial for managing skin side effects in metastatic melanoma patients using vemurafenib and ipilimumab.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

New treatments for advanced skin cancer are improving patient outcomes, but drug resistance and finding the right treatment combinations are still big challenges.

New melanoma treatments can cause skin side effects, including skin cancer and rashes, but combining treatments may reduce these risks.

Targeted therapies for lung cancer are effective but require careful management of side effects to benefit patients.

Cancer treatments targeting specific cells and the immune system can cause skin, mouth, hair, and nail problems, affecting patients' quality of life and treatment adherence.

Scalp melanoma, a deadly skin cancer, is often found late due to its hard-to-see location, especially in older men. Early detection, possible treatments, and the role of hairdressers in spotting it early are discussed. More research is needed to improve detection and treatment.

Melanoma's complexity requires personalized treatments due to key genetic mutations and tumor-initiating cells.

Cancer treatments targeting specific cells often cause skin, hair, and nail problems, affecting patients' lives and requiring careful management.

Modern skin cancer treatments can cause skin side effects and hair loss, affecting patients' quality of life.

Cancer treatments often cause hair disorders, significantly affecting patients' quality of life, and better management methods are needed.

Spanish experts provided guidelines for treating skin side effects in cancer patients on new therapies, stressing early action and teamwork.

Cancer survivors often experience worse skin problems from treatment than expected, and working with dermatologists could help improve their condition.

New targeted cancer drugs can cause skin side effects, and managing them requires patient education and timely care.

The symposium highlighted the importance of understanding disease mechanisms for targeted dermatology treatments.

Men with a certain type of hair loss often use facial moisturizers, and a specific antibiotic treatment may help another hair condition.

Patients on dabrafenib and trametinib for melanoma often experience skin side effects.

Targeted anticancer therapies can cause severe side effects similar to traditional chemotherapy, but with different types.

Using protein degradation to fight cancer drug resistance shows promise but needs more precise targeting and fewer side effects.

Intralesional therapy for keratoacanthoma is effective and has fewer side effects than systemic treatments.

Most children with CNS tumors on targeted therapy had skin reactions, which were generally treatable without stopping the therapy.

Preventive measures and effective management are crucial for reducing skin side effects in cancer treatment.

Vemurafenib causes skin side effects similar to RASopathies, requiring regular skin checks and UVA protection.

Dabrafenib was effective and well tolerated in treating thyroid cancer with a specific mutation.

The combination treatment showed a higher response rate but no significant survival benefits.

BRAF inhibitors for melanoma often cause skin side effects, but they can be managed with proper care.

A man's severe skin reaction from cancer treatment improved with early diagnosis and proper medication.

New cancer treatments are less harmful to hair but can still cause hair loss, color, shape, and growth changes.